Published in Vaccine Weekly, June 19th, 2002
Treatment of brain cancer is complicated by being located in an immunologically privileged location of the central nervous system. M. Toda and colleagues at the Institute for Advanced Medical Research in Tokyo used BALB/c mice, which produce intracranial and subcutaneous mouse CT26 colon adenocarcinoma tumors, for testing a novel approach to brain cancer treatment.
The researchers injected a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.